Inventor · disambiguated record
Henning Ralf Stennicke
Also filed as: STENNICKE HENNING · STENNICKE HENNING R · STENNICKE HENNING RALF
11 granted patents·29 pending applications·126 citations·filing 1994–2021
88Inventor score
Top patents by PatentIndex Score
40 records- 0195US7524813B2Selectively conjugated peptides and methods of making the sameNOVO NORDISK HEALTHCARE AG·Filed 2006·Granted Apr 28, 2009·72 cites·3 claims
- 0284US5945329ACustomized proteasesCARLSBERG AS·Filed 1997·Granted Aug 31, 1999·39 cites·32 claims
- 0372US2022073895A1Human coagulation factor vii polypeptidesNOVO NORDISK HEALTHCARE AG·Filed 2021·Application pending·0 cites
- 0470US9150848B2Conjugated factor VIII moleculesNOVO NORDISK AS·Filed 2014·Granted Oct 6, 2015·1 cites·12 claims
- 0569US8536126B2Conjugated factor VIII moleculesNOVO NORDISK AS·Filed 2013·Granted Sep 17, 2013·1 cites·7 claims
- 0663US8859731B2Selective modification of proteinsKOFOD-HANSEN MIKAEL·Filed 2011·Granted Oct 14, 2014·1 cites·12 claims
- 0762US10906960B2Factor VIII variants having a decreased cellular uptakeNOVO NORDISK AS·Filed 2018·Granted Feb 2, 2021·0 cites·5 claims
- 0862US2020010820A1Human coagulation factor vii polypeptidesNOVO NORDISK HEALTHCARE AG·Filed 2019·Application pending·0 cites
- 0960US2010303786A1Stabilisation of Liquid-Formulated Factor VII(A) Polypeptides by Aldehyde-Containing CompoundsNOVO NORDISK HEALTHCARE AG·Filed 2008·Application pending·0 cites
- 1059US10179905B2Factor VII conjugatesNOVO NORDISK HEALTHCARE AG·Filed 2017·Granted Jan 15, 2019·0 cites·14 claims
- 1159US2015259665A1Factor vii conjugatesNOVO NORDISK HEALTHCARE AG·Filed 2013·Application pending·0 cites
- 1258US2006160741A1Dimeric TF antagonistsNOVO NORDISK AS·Filed 2006·Application pending·0 cites
- 1357US2013189239A1Conjugated Factor VIII MoleculesBOLT GERT·Filed 2009·Application pending·0 cites
- 1457US2009253166A1Conjugation of PeptidesNOVO NORDISK AS·Filed 2009·Application pending·0 cites
- 1556US10047142B2Factor VIII variants having a decreased cellular uptakeNOVO NORDISK AS·Filed 2016·Granted Aug 14, 2018·0 cites·6 claims
- 1656US2016002314A1Factor viii variants having a decreased cellular uptakeNOVO NORDISK AS·Filed 2015·Application pending·0 cites
- 1756US2013040888A1Factor VIII Molecules With Reduced VWF BindingNOVO NORDISK AS·Filed 2011·Application pending·0 cites
- 1855US2017198274A1Human Coagulation Factor VII PolypeptidesNOVO NORDISK HEALTHCARE AG·Filed 2017·Application pending·0 cites
- 1955US2017020992A1Factor VIII Molecules with Reduced VWF BindingNOVO NORDISK AS·Filed 2016·Application pending·0 cites
- 2054US2009055942A1Human Coagulation Factor VII PolypeptidesNOVO NORDISK HEALTHCARE AG·Filed 2006·Application pending·0 cites
- 2153US2009252720A1Prolonged FIX Analogues and DerivativesNOVO NORDISK HEALTHCARE AG·Filed 2007·Application pending·0 cites
- 2252US2015376262A1Factor VIII Molecules With Reduced VWF BindingNOVO NORDISK AS·Filed 2015·Application pending·0 cites
- 2351US6187579B1Customized proteasesCARLSBERG AS·Filed 1994·Granted Feb 13, 2001·4 cites·34 claims
- 2451US2016264645A1Stabilized Factor VIII VariantsNOVO NORDISK AS·Filed 2016·Application pending·0 cites
- 2550US2004072755A1TF antagonistFiled 2003·Application pending·0 cites
- 2650US2016251409A1Targeted Delivery of Factor VIII Proteins to PlateletsNOVO NORDISK AS·Filed 2016·Application pending·0 cites
- 2750US2003229018A1Dimeric TF antagonistFiled 2003·Application pending·0 cites
- 2849US2016222086A1Conjugated Factor VIII MoleculesNOVO NORDISK AS·Filed 2015·Application pending·0 cites
- 2947US9321827B2Factor VIII variants having a decreased cellular uptakeMEEMS HENRIET·Filed 2011·Granted Apr 26, 2016·0 cites·6 claims
- 3047US2011040073A1Covalent Factor VII-Tissue Factor ComplexNOVO NORDISK HEALTHCARE AG·Filed 2007·Application pending·0 cites
- 3145US2013183280A1Stabilized factor viii variantsOESTERGAARD HENRIK·Filed 2011·Application pending·0 cites
- 3244US2007141662A1Fusion proteins and methods of cleavage of such proteinsBURNHAM INST·Filed 2006·Application pending·0 cites
- 3343US5985627AModified carboxypeptidaseCARLSBERG LAB·Filed 1997·Granted Nov 16, 1999·8 cites·28 claims
- 3443US2009130086A1FXIII Variants with Improved PropertiesNOVO NORDISK HEALTHCARE AG·Filed 2006·Application pending·0 cites
- 3543US2009176967A1Conjugation of FVIINOVO NORDISK HEALTHCARE AG·Filed 2005·Application pending·0 cites
- 3641US2015307865A1Coagulation factor vii polypeptidesNOVO NORDISK HEALTHCARE AG·Filed 2013·Application pending·0 cites
- 3741US2012093840A1Targeted delivery of factor viii proteins to plateletsOESTERGAARD HENRIK·Filed 2010·Application pending·0 cites
- 3836US2009041744A1Dimeric and Multimeric FVIIa CompoundsNOVO NORDISK HEALTHCARE AG·Filed 2006·Application pending·0 cites
- 3932US2006018831A1TF binding agent and use thereofH S RIGSHOSPITALET·Filed 2005·Application pending·0 cites
- 4023US2001010923A1Modified carboxypeptidaseFiled 1999·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Henning Ralf Stennicke files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →